Skip to the page

Data / Drug companies / SCH Global Services Private Limited

SCH Global Services Private Limited: 58 products in the FDA NDC directory, labeler code 85207

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

SCH Global Services Private Limited (labeler code 85207) lists 58 products in the FDA National Drug Code Directory. By type: 58 bulk ingredients. Its main marketing category is bulk ingredients for compounding. The newest product started marketing on October 20, 2026.

The request: Watch SCH Global Services Private Limited (FDA labeler code 85207): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
85207
Products in commercial distribution
58
Packages
421
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule III 12
Started marketing in the last 12 months
40
Earliest marketing start
January 24, 2025
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients for compounding4679.3%
Bulk ingredients1220.7%

Products by type

TypeProductsShare
Bulk ingredients58100%

Dosage forms

Dosage formProductsShare
Powder58100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Oxandrolone85207-070PowderBulk ingredients for compoundingOctober 20, 2026
Stanozolol85207-069PowderBulk ingredients for compoundingOctober 20, 2026
Tolazoline hcl85207-067PowderBulk ingredients for compoundingJuly 27, 2026
Bpc 157 acetate85207-068PowderBulk ingredients for compoundingJuly 24, 2026
Bremelanotide acetate (pt 141)85207-066PowderBulk ingredients for compoundingJuly 24, 2026
Mots-c acetate85207-065PowderBulk ingredients for compoundingJuly 24, 2026
Dihexa acetate85207-064PowderBulk ingredients for compoundingJuly 24, 2026
Ibutamoren mesylate (mk - 677)85207-063PowderBulk ingredients for compoundingApril 20, 2026
Cjc-1295 acetate85207-061PowderBulk ingredients for compoundingApril 7, 2026
Epithalon acetate85207-060PowderBulk ingredients for compoundingApril 7, 2026
Slu-pp-33285207-059PowderBulk ingredients for compoundingApril 1, 2026
5-amino-1-methyl-1-quinolinium iodide anhydrous85207-058PowderBulk ingredients for compoundingMarch 31, 2026
Elamipretide (ss-31) acetate85207-057PowderBulk ingredients for compoundingMarch 18, 2026
Anamorelin hydrochloride85207-056PowderBulk ingredients for compoundingMarch 18, 2026
Vardenafil hydrochloride trihydrate85207-062PowderBulk ingredients for compoundingMarch 16, 2026
Metronidazole benzoate85207-054PowderBulk ingredients for compoundingMarch 16, 2026
Potassium bromide85207-053PowderBulk ingredients for compoundingMarch 16, 2026
Testosterone cypionate85207-051PowderBulk ingredients for compoundingMarch 3, 2026
Testosterone phenylpropionate85207-050PowderBulk ingredients for compoundingMarch 3, 2026
Testosterone propionate85207-049PowderBulk ingredients for compoundingMarch 3, 2026
Testosterone decanoate bp85207-048PowderBulk ingredients for compoundingMarch 3, 2026
Dehydroepiandrosterone ih85207-047PowderBulk ingredients for compoundingMarch 3, 2026
Dydrogesterone85207-046PowderBulk ingredients for compoundingMarch 3, 2026
Progesterone85207-045PowderBulk ingredients for compoundingMarch 3, 2026
Norethindrone acetate85207-044PowderBulk ingredients for compoundingMarch 3, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.